Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia after Digoxin Therapy

Medicina (Kaunas). 2020 May 7;56(5):223. doi: 10.3390/medicina56050223.

Abstract

We present a special case of fetal supraventricular tachycardia detected at 34 weeks gestation. Fetal hydrops was noted on ultrasound upon admission. Normal fetal heart rate was maintained for three weeks by maternal administration of digoxin. A live infant was delivered via caesarian section at 37 weeks gestation. This clinical case demonstrated that pharmacological treatment can be effective and helps to prolong pregnancy safely.

Keywords: digoxin; fetal hydrops; fetal tachyarrhytmia; sotalol.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use
  • Digoxin / adverse effects*
  • Digoxin / pharmacology*
  • Digoxin / therapeutic use
  • Female
  • Humans
  • Hydrops Fetalis / drug therapy*
  • Hydrops Fetalis / physiopathology
  • Pregnancy
  • Tachycardia, Supraventricular / drug therapy*
  • Ultrasonography, Prenatal / methods

Substances

  • Anti-Arrhythmia Agents
  • Digoxin